Evidence map›Paper›PMID 24817273›Full record

ArticlePloS one2014

The chromatin "landscape" of a murine adult β-globin gene is unaffected by deletion of either the gene promoter or a downstream enhancer.

Brenda Cadiz-Rivera, George Fromm, Christina de Vries, Jennifer Fields, Kathleen E McGrath, Steven Fiering, Michael Bulger

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Brenda Cadiz-RiveraDepartment of Pediatrics, University of Rochester Medical Center and Center for Pediatric Biomedical Research, Rochester, New York, United States of America.
George FrommDepartment of Pediatrics, University of Rochester Medical Center and Center for Pediatric Biomedical Research, Rochester, New York, United States of America; National Institute for Environmental Health Sciences, NIH, Research Triangle Park, North Carolina, United States of America.
Christina de VriesDepartment of Pediatrics, University of Rochester Medical Center and Center for Pediatric Biomedical Research, Rochester, New York, United States of America.
Jennifer FieldsDepartment of Microbiology and Immunology, Dartmouth Medical School, Hanover, New Hampshire, United States of America.
Kathleen E McGrathDepartment of Pediatrics, University of Rochester Medical Center and Center for Pediatric Biomedical Research, Rochester, New York, United States of America.
Steven FieringDepartment of Microbiology and Immunology, Dartmouth Medical School, Hanover, New Hampshire, United States of America.
Michael BulgerDepartment of Pediatrics, University of Rochester Medical Center and Center for Pediatric Biomedical Research, Rochester, New York, United States of America.
University of Rochester Medical Center · USDartmouth College · USNational Institute of Environmental Health Sciences · US

Funding

Training in Cellular, Biochemical and Molecular SciencesT32GM068411 · NIGMS · UNIVERSITY OF ROCHESTER · PI MAQUAT, LYNNE E · 2005 to 2019
$3.9M
Function of active chromatin domains in erythropoiesisR01DK070687 · NIDDK · UNIVERSITY OF ROCHESTER · PI BULGER, MICHAEL D · 2007 to 2016
$2.5M
NIDDK NIH HHS R01 DK070687NIDDK NIH HHS R01-DK070687-06A1NIGMS NIH HHS GM068411NIGMS NIH HHS T32 GM068411
6 · The paper itself

Abstract

In mammals, the complex tissue- and developmental-specific expression of genes within the β-globin cluster is known to be subject to control by the gene promoters, by a locus control region (LCR) located upstream of the cluster, and by sequence elements located across the intergenic regions. Despite extensive investigation, however, the complement of sequences that is required for normal regulation of chromatin structure and gene expression within the cluster is not fully defined. To further elucidate regulation of the adult β-globin genes, we investigate the effects of two deletions engineered within the endogenous murine β-globin locus. First, we find that deletion of the β2-globin gene promoter, while eliminating β2-globin gene expression, results in no additional effects on chromatin structure or gene expression within the cluster. Notably, our observations are not consistent with competition among the β-globin genes for LCR activity. Second, we characterize a novel enhancer located 3' of the β2-globin gene, but find that deletion of this sequence has no effect whatsoever on gene expression or chromatin structure. This observation highlights the difficulty in assigning function to enhancer sequences identified by the chromatin "landscape" or even by functional assays.

Indexed as

Sequence DeletionAnimalsbeta-GlobinsCell Line, TumorChromatinEnhancer Elements, GeneticFemaleGene Expression RegulationLocus Control RegionMaleMice, 129 StrainMice, Inbred BALB CPromoter Regions, GeneticReverse Transcriptase Polymerase Chain Reactionbeta-GlobinsChromatin

Identifiers

PMID24817273
PMCPMC4015891
OpenAlexW2083016012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.